معرفی
Ying-Hsia Chu serves as Assistant Professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota, where she leads research at the intersection of molecular pathology and head/neck-thyroid oncology. Her work bridges diagnostic histopathology with genomic characterization to address clinically challenging carcinomas.
Research Focus: Dr. Chu specializes in gene fusion discovery (e.g., STAT6, RAF1, NOTCH1), non-coding RNA mechanisms in cancer progression, and development of RNA sequencing diagnostics for sinonasal tract and thyroid malignancies. Her fingerprint analysis confirms dominant expertise in neoplasm (100%), thyroid carcinoma (84%), and phosphotransferase pathways (69%), with significant contributions to understanding long non-coding RNAs in anaplastic carcinomas.
Publication Trends: Analysis of her 35 publications (2013-2025) reveals accelerating output since 2020, with 2022-2025 works emphasizing actionable genomic alterations (e.g., FGFR rearrangements, MET skipping) and expanded histological spectra in HPV-associated carcinomas. This trajectory demonstrates increasing influence in precision oncology diagnostics, particularly through multi-institutional collaborations.
Collaborative Impact: Dr. Chu's nationwide studies on oral cavity cancer (e.g., 2023 neck dissection analysis with 18 Scopus citations) demonstrate translational impact on surgical guidelines. Her work engages international networks including Taiwanese institutions and major US cancer centers, though specific laboratory structures remain unreported in available materials.
